Warning: The NCBI web site requires JavaScript to function. more...
An exo-cell assay for examining real-time gamma-secretase activity and inhibition.
Shelton CC, Tian Y, Frattini MG, Li YM.
Mol Neurodegener. 2009 Jun 2;4:22.
Related citations
A miniaturized 1536-well format gamma-secretase assay.
Shelton CC, Tian Y, Shum D, Radu C, Djaballah H, Li YM.
Assay Drug Dev Technol. 2009 Oct;7(5):461-70.
Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies.
Evin G, Sernee MF, Masters CL.
CNS Drugs. 2006;20(5):351-72. Review.
Gamma-secretase exists on the plasma membrane as an intact complex that accepts substrates and effects intramembrane cleavage.
Chyung JH, Raper DM, Selkoe DJ.
J Biol Chem. 2005 Feb 11;280(6):4383-92. Epub 2004 Nov 29.
Presenilin endoproteolysis mediated by an aspartyl protease activity pharmacologically distinct from gamma-secretase.
Campbell WA, Reed ML, Strahle J, Wolfe MS, Xia W.
J Neurochem. 2003 Jun;85(6):1563-74.
Activity of gamma-secretase on substrates other than APP.
Lleó A.
Curr Top Med Chem. 2008;8(1):9-16. Review.
Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.
Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ.
Nature. 1999 Apr 8;398(6727):513-7.
The discovery and role of CD147 as a subunit of gamma-secretase complex.
Zhou S, Zhou H, Walian PJ, Jap BK.
Drug News Perspect. 2006 Apr;19(3):133-8. Review.
In vitro gamma-secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc.
Hoke DE, Tan JL, Ilaya NT, Culvenor JG, Smith SJ, White AR, Masters CL, Evin GM.
FEBS J. 2005 Nov;272(21):5544-57.
Regulation of gamma-secretase activity in Alzheimer's disease.
Biochemistry. 2007 Mar 13;46(10):2553-63. Epub 2007 Feb 14.
In vivo reconstitution of gamma-secretase in Drosophila results in substrate specificity.
Stempfle D, Kanwar R, Loewer A, Fortini ME, Merdes G.
Mol Cell Biol. 2010 Jul;30(13):3165-75. Epub 2010 Apr 26.
Processing of Notch and amyloid precursor protein by gamma-secretase is spatially distinct.
Tarassishin L, Yin YI, Bassit B, Li YM.
Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17050-5. Epub 2004 Nov 24.
Activity-dependent isolation of the presenilin- gamma -secretase complex reveals nicastrin and a gamma substrate.
Esler WP, Kimberly WT, Ostaszewski BL, Ye W, Diehl TS, Selkoe DJ, Wolfe MS.
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2720-5. Epub 2002 Feb 26.
Purification, pharmacological modulation, and biochemical characterization of interactors of endogenous human gamma-secretase.
Winkler E, Hobson S, Fukumori A, Dümpelfeld B, Luebbers T, Baumann K, Haass C, Hopf C, Steiner H.
Biochemistry. 2009 Feb 17;48(6):1183-97.
[Targeting the structure and function relationships of the gamma-secretase for the development of Alzheimer's disease].
Tomita T.
Rinsho Shinkeigaku. 2008 Nov;48(11):907-9. Review. Japanese.
At the frontline of Alzheimer's disease treatment: gamma-secretase inhibitor/modulator mechanism.
Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):295-300. Epub 2007 Nov 24. Review.
Gene expression profiling in cells with enhanced gamma-secretase activity.
Magold AI, Cacquevel M, Fraering PC.
PLoS One. 2009 Sep 18;4(9):e6952.
gamma-Secretase: characterization and implication for Alzheimer disease therapy.
Xu M, Lai MT, Huang Q, DiMuzio-Mower J, Castro JL, Harrison T, Nadin A, Neduvelil JG, Shearman MS, Shafer JA, Gardell SJ, Li YM.
Neurobiol Aging. 2002 Nov-Dec;23(6):1023-30.
gamma-Secretase modulators.
Wolfe MS.
Curr Alzheimer Res. 2007 Dec;4(5):571-3. Review.
Nectin-1alpha, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/gamma-secretase-like cleavage.
Kim DY, Ingano LA, Kovacs DM.
J Biol Chem. 2002 Dec 20;277(51):49976-81. Epub 2002 Oct 9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on